4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000100
Chairperson & CEO sold 9,500 shares at an average $530.91 ($5,043,689)
- Chairperson & CEO acquired 9,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROTHBLATT MARTINE A · Chairperson & CEO
Table I: Non-derivative
11 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-07-16 | Exercise or conversion : show line 1 in the form 10b5-1 | +9,500 | $135.42 | $1,286,490 | 333,943 | I |
| 2026-07-16 | Sale : show line 2 in the form 10b5-1 | −80 | $527.31 | $42,185 | 333,863 | I |
| 2026-07-16 | Sale : show line 3 in the form 10b5-1 | −1,400 | $528.42 | $739,783 | 332,463 | I |
| 2026-07-16 | Sale : show line 4 in the form 10b5-1 | −3,057 | $529.46 | $1,618,572 | 329,406 | I |
| 2026-07-16 | Sale : show line 5 in the form 10b5-1 | −1,924 | $530.14 | $1,019,999 | 327,482 | I |
| 2026-07-16 | Sale : show line 6 in the form 10b5-1 | −520 | $532.14 | $276,712 | 326,962 | I |
| 2026-07-16 | Sale : show line 7 in the form 10b5-1 | −440 | $533.28 | $234,644 | 326,522 | I |
| 2026-07-16 | Sale : show line 8 in the form 10b5-1 | −1,198 | $534.31 | $640,101 | 325,324 | I |
| Open-market sales · 9,500 sh · avg $530.91 · $5,043,689 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-07-16 | Exercise or conversion : show line 12 in the form 10b5-1 Stock Option | −9,500 | 331,910 | I |
Loading xslF345X06/primarydocument.xml…